Skip to main content
Top
Published in: Sleep and Breathing 1/2017

01-03-2017 | Neurology • Original Article

Brain pathway differences between Parkinson’s disease patients with and without REM sleep behavior disorder

Authors: Mina Ansari, Farzaneh Rahmani, Mahsa Dolatshahi, Atefe Pooyan, Mohammad Hadi Aarabi

Published in: Sleep and Breathing | Issue 1/2017

Login to get access

Abstract

Purpose

REM (rapid eye movement) sleep behavior disorder (RBD) is characterized by increased muscle tone and violent limb movements and is a usual symptom of the early stages of Parkinson’s disease (PD). PD patients with RBD represent faster motor and cognitive dysfunction progression. However, there are limited studies on possible structural brain changes underpinning this disorder.

Methods

Diffusion magnetic resonance imaging (DMRI) was used to assess whether microstructural abnormalities in the brain of 23 RBD positive PD are detectable compared to 31 RBD negative PD. DMRI scans were analyzed without a prior hypothesis. Diffusion MRI connectometry was used to carry out group analysis between age and gender matched PD patients with and without RBD. Diffusion MRI connectometry is based on spin distribution function (SDF) which quantifies the density of diffusing water and is more sensitive to psychological differences between groups.

Results

Patients with RBD positive showed microstructural white matter changes in the left and right cingulum, inferior front occipital fasciculus (IFOF), bilateral corticospinal tracts (CST), and middle cerebellar peduncles (MCPs), compared to patients without RBD.

Conclusions

White matter alterations in the cingulum, IFOF regions, and corpus callosum might explain faster cognitive deterioration in PD patients with RBD, in terms of visual recognition and visuospatial dysfunction and executive function. Disturbed brain structural tissue markers in CST in PD + RBD patients, could be justified in the light of faster motor progression in these patients.
Literature
1.
go back to reference Munhoz RP et al (2015) Non-motor signs in Parkinson’s disease: a review. Arq Neuropsiquiatr 73(5):454–462CrossRefPubMed Munhoz RP et al (2015) Non-motor signs in Parkinson’s disease: a review. Arq Neuropsiquiatr 73(5):454–462CrossRefPubMed
2.
go back to reference Postuma RB et al (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77(5):830–839CrossRefPubMed Postuma RB et al (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77(5):830–839CrossRefPubMed
3.
go back to reference Slow EJ, Postuma RB, Lang AE (2014) Implications of nocturnal symptoms towards the early diagnosis of Parkinson’s disease. J Neural Transm (Vienna) 121(Suppl 1):S49–S57CrossRef Slow EJ, Postuma RB, Lang AE (2014) Implications of nocturnal symptoms towards the early diagnosis of Parkinson’s disease. J Neural Transm (Vienna) 121(Suppl 1):S49–S57CrossRef
4.
go back to reference Postuma RB et al (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 132(Pt 12):3298–3307CrossRefPubMed Postuma RB et al (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 132(Pt 12):3298–3307CrossRefPubMed
5.
go back to reference Lim JS et al (2016) Neural substrates of rapid eye movement sleep behavior disorder in Parkinson’s disease. Parkinsonism Relat Disord 23:31–36CrossRefPubMed Lim JS et al (2016) Neural substrates of rapid eye movement sleep behavior disorder in Parkinson’s disease. Parkinsonism Relat Disord 23:31–36CrossRefPubMed
6.
go back to reference Zhang JR et al (2016) Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease. Chin Med J 129(4):379–385CrossRefPubMedPubMedCentral Zhang JR et al (2016) Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease. Chin Med J 129(4):379–385CrossRefPubMedPubMedCentral
7.
go back to reference Scherfler C et al (2011) White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 69(2):400–407CrossRefPubMed Scherfler C et al (2011) White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 69(2):400–407CrossRefPubMed
8.
go back to reference Mitterling T, Högl B (2013) Magnetic resonance imaging in rapid eye movement sleep behavior disorder: diffusion tensor imaging and voxel-based morphometry. Sleep and Biological Rhythms 11(S1):52–55CrossRef Mitterling T, Högl B (2013) Magnetic resonance imaging in rapid eye movement sleep behavior disorder: diffusion tensor imaging and voxel-based morphometry. Sleep and Biological Rhythms 11(S1):52–55CrossRef
9.
go back to reference Miyamoto M et al (2012) Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder. Sleep Med 13(1):102–106CrossRefPubMed Miyamoto M et al (2012) Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder. Sleep Med 13(1):102–106CrossRefPubMed
11.
go back to reference Ford AH et al (2015) Rapid eye movement sleep behavior disorder in Parkinson’s disease: magnetic resonance imaging study. Mov Disord 28(6):832–836CrossRef Ford AH et al (2015) Rapid eye movement sleep behavior disorder in Parkinson’s disease: magnetic resonance imaging study. Mov Disord 28(6):832–836CrossRef
12.
go back to reference Boucetta S et al (2016) Structural brain alterations associated with rapid eye movement sleep behavior disorder in Parkinson’s disease. Sci Rep 6:26782CrossRefPubMedPubMedCentral Boucetta S et al (2016) Structural brain alterations associated with rapid eye movement sleep behavior disorder in Parkinson’s disease. Sci Rep 6:26782CrossRefPubMedPubMedCentral
13.
go back to reference Reinoso-Suarez F et al (2001) Brain structures and mechanisms involved in the generation of REM sleep. Sleep Med Rev 5(1):63–77CrossRefPubMed Reinoso-Suarez F et al (2001) Brain structures and mechanisms involved in the generation of REM sleep. Sleep Med Rev 5(1):63–77CrossRefPubMed
15.
go back to reference Yeh FC et al (2013) Deterministic diffusion fiber tracking improved by quantitative anisotropy. PLoS One 8(11):e80713 Yeh FC et al (2013) Deterministic diffusion fiber tracking improved by quantitative anisotropy. PLoS One 8(11):e80713
16.
go back to reference Tatura R, Kraus T, Giese A, Arzberger T, Buchholz M, Hoglinger G, Muller U (2016) Parkinson’s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2016.09.028 Tatura R, Kraus T, Giese A, Arzberger T, Buchholz M, Hoglinger G, Muller U (2016) Parkinson’s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus. Parkinsonism Relat Disord. doi:10.​1016/​j.​parkreldis.​2016.​09.​028
17.
go back to reference Zheng Z et al (2014) DTI correlates of distinct cognitive impairments in Parkinson’s disease. Hum Brain Mapp 35(4):1325–1333CrossRefPubMed Zheng Z et al (2014) DTI correlates of distinct cognitive impairments in Parkinson’s disease. Hum Brain Mapp 35(4):1325–1333CrossRefPubMed
18.
19.
go back to reference Kamagata K et al (2012) White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. AJNR Am J Neuroradiol 33(5):890–895CrossRefPubMed Kamagata K et al (2012) White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. AJNR Am J Neuroradiol 33(5):890–895CrossRefPubMed
20.
go back to reference Pena MCS et al (2008) Vsuospatial cognitive tests for the evaluation of patients with Parkinson’s disease. Dement Neuropsychol 2(3):201–205CrossRef Pena MCS et al (2008) Vsuospatial cognitive tests for the evaluation of patients with Parkinson’s disease. Dement Neuropsychol 2(3):201–205CrossRef
21.
go back to reference Canu, E., et al., 2015 Brain structural and functional connectivity in Parkinson’s disease with freezing of gait. Hum Brain Mapp Canu, E., et al., 2015 Brain structural and functional connectivity in Parkinson’s disease with freezing of gait. Hum Brain Mapp
22.
go back to reference Chen B et al (2015) Changes in anatomical and functional connectivity of Parkinson’s disease patients according to cognitive status. Eur J Radiol 84(7):1318–1324CrossRefPubMed Chen B et al (2015) Changes in anatomical and functional connectivity of Parkinson’s disease patients according to cognitive status. Eur J Radiol 84(7):1318–1324CrossRefPubMed
23.
go back to reference Almairac F et al (2015) The left inferior fronto-occipital fasciculus subserves language semantics: a multilevel lesion study. Brain Struct Funct 220(4):1983–1995CrossRefPubMed Almairac F et al (2015) The left inferior fronto-occipital fasciculus subserves language semantics: a multilevel lesion study. Brain Struct Funct 220(4):1983–1995CrossRefPubMed
24.
go back to reference Luo C et al (2016) Cortical thinning in drug-naive Parkinson’s disease patients with depression. J Neurol 263(10):2114–2119CrossRefPubMed Luo C et al (2016) Cortical thinning in drug-naive Parkinson’s disease patients with depression. J Neurol 263(10):2114–2119CrossRefPubMed
26.
go back to reference Marelli, S., et al., 2016 National validation and proposed revision of REM sleep behavior disorder screening questionnaire (RBDSQ). J Neurol Marelli, S., et al., 2016 National validation and proposed revision of REM sleep behavior disorder screening questionnaire (RBDSQ). J Neurol
Metadata
Title
Brain pathway differences between Parkinson’s disease patients with and without REM sleep behavior disorder
Authors
Mina Ansari
Farzaneh Rahmani
Mahsa Dolatshahi
Atefe Pooyan
Mohammad Hadi Aarabi
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 1/2017
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-016-1435-8

Other articles of this Issue 1/2017

Sleep and Breathing 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine